Skip to main content
Clinical Trials/NCT04732936
NCT04732936
Completed
Not Applicable

Feasibility Study of a Temporary Peripheral Nerve Stimulator

Epineuron Technologies Inc.3 sites in 1 country25 target enrollmentApril 1, 2021
ConditionsNerve Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nerve Injury
Sponsor
Epineuron Technologies Inc.
Enrollment
25
Locations
3
Primary Endpoint
Static Two Point Discrimination
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

A novel temporary peripheral nerve stimulator will be evaluated for safety, usability, and preliminary efficacy.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
June 21, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Are between 18-65 years old
  • Have a Sunderland II-V peripheral nerve injury of the upper extremity
  • Are receiving surgery within 14 days of injury

Exclusion Criteria

  • Nerve plexus injuries (e.g. brachial plexus)
  • Nerve gap requiring graft/conduit, or extreme joint flexion
  • Polyneuropathies
  • Cognitive impairment and non-English-speaking
  • Uncontrolled diabetes
  • Surgical intervention \> 14 days of injury
  • Co-enrollment in another clinical trial
  • Pregnant women

Outcomes

Primary Outcomes

Static Two Point Discrimination

Time Frame: 6 months

Measurement of spatial determination

Semmes-Weinstein Monofilament Test

Time Frame: 6 months

Measurement of pressure sensitivity

DASH Questionnaire

Time Frame: 6 months

Validated questionnaire for functionality in upper extremity injury

Patient Tolerance to Therapy Questionnaire

Time Frame: Immediately after procedure

Secondary Outcomes

  • Device Usability Questionnaire(Immediately after procedure)
  • Safety(6 months)

Study Sites (3)

Loading locations...

Similar Trials